June 28, 2018
Sandoz Japan Head Jason Hoffe Jason Hoffe, president of the Japan unit of Sandoz, said on June 27 that the country’s first Rituxan (rituximab) biosimilar it rolled out in January together with local ally Kyowa Hakko Kirin grabbed a market...read more